Exascale Labs Holdings Inc. (XLAB) Completes Business Combination; Shares Begin Trading

What Happened

• Exascale Labs Holdings Inc. (PubCo / ticker XLAB) filed an 8‑K on Sept. 2, 2026 reporting the closing of its Business Combination. As part of the closing, PubCo’s Class A ordinary shares and warrants began trading on Nasdaq under the symbols XLAB and XLABW on August 28, 2026; the former BCAR units, shares and warrants ceased trading. PubCo filed an Amended and Restated Certificate of Incorporation and adopted new Bylaws in connection with the transaction. The company also issued a press release announcing the closing on August 27, 2026 (Exhibit 99.2).

Key Details

• Nasdaq listing: PubCo Class A Ordinary Stock and PubCo Warrants began trading on Nasdaq as “XLAB” and “XLABW” on August 28, 2026.
• Lock‑up agreements: Former Exascale stockholders and SAFE holders agreed not to sell certain PubCo shares for the earlier of (i) six months after the Closing Date or (ii) the date of a qualifying liquidity transaction; forms attached as Exhibits 10.1 and 10.2.
• Indemnification: PubCo entered indemnification agreements with each director and executive officer covering certain expenses (including attorneys’ fees, judgments, fines and settlements); form attached as Exhibit 10.3.
• Corporate/structural changes: Amended & Restated Certificate of Incorporation and new Bylaws were filed (Exhibits 3.1 and 3.2). BCAR ceased to be a shell company as of the Closing Date.

Why It Matters

• The listing under XLAB/XLABW means the combined company is now publicly tradable and will have market visibility and liquidity for shares.
• The six‑month lock‑ups reduce the immediate sellable float from former holders, which can affect near‑term share supply.
• Indemnification clauses are standard for newly public companies and protect current directors/officers from personal liability costs tied to their service, which can influence governance and risk allocation.
• Investors should review the referenced Proxy Statement/Prospectus sections (e.g., “The Business Combination Proposal,” “Organizational Documents Proposal,” and “Description of PubCo’s Securities”) and the exhibits in the 8‑K for full legal and governance details before making investment decisions.